SIREN : 419129721
BIOBREIZH is a French company founded 28 years ago, specialized in the sector Culture de légumes, de melons, de racines et de tubercules. Based in LANDIVISIAU (29400), this company of category PME shows in 2025 a revenue of 27.2 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2025 | 2024 | 2023 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 27 224 565 € | 25 026 353 € | N/C | N/C | N/C | N/C |
| Net income | 326 024 € | 214 556 € | 313 281 € | 588 565 € | 128 075 € | 93 305 € |
| EBITDA | 380 007 € | 272 056 € | N/C | N/C | N/C | N/C |
| Net margin | 1.2% | 0.9% | N/C | N/C | N/C | N/C |
In 2025, BIOBREIZH achieves revenue of 27.2 M€. Over the period 2024-2025, the company shows strong growth with a CAGR (compound annual growth rate) of +8.8%. Vs 2024: +9%. After deducting consumption (26.2 M€), gross margin stands at 1.1 M€, i.e. a rate of 4%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 380 k€, representing 1.4% of revenue. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 326 k€, i.e. 1.2% of revenue. This profit can be retained or distributed to shareholders.
27 224 565 €
1 070 828 €
380 007 €
302 657 €
326 024 €
1.4%
The debt ratio (= Financial debt / Equity x 100) stands at 103%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 45%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 8.4 years of cash flow to repay all financial debt. Beyond 7 years, banks generally consider credit risk as high. Cash flow represents 1.2% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.
103.38%
44.656%
1.212%
8.369
71.4%
In 2025, the debt ratio of BIOBREIZH (103.38) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2025, the financial autonomy of BIOBREIZH (44.7%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
In 2025, the repayment capacity of BIOBREIZH (8.37) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.
The liquidity ratio (= Current assets / Current liabilities) stands at 1244.14. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 1.0x. Danger: operating income does not cover interest charges, unsustainable situation.
1244.141
0.978
In 2025, the liquidity ratio of BIOBREIZH (1244.14) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
In 2025, the interest coverage of BIOBREIZH (1.0x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 22 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 5 days. The company must finance 17 days of gap between collections and payments. Overall, WCR represents 54 days of revenue, i.e. 4.1 M€ to permanently finance.
4 088 857 €
22 j
5 j
0 j
54 j
Based on 138 transactions of similar company sales (all years), the value of BIOBREIZH is estimated at 4 177 930 € (range 1 440 219€ - 7 156 421€). With an EBITDA of 380 007€, the sector multiple of 3.3x is applied. The price/revenue ratio is 0.41x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 138 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare BIOBREIZH with other companies in the same sector:
Voir toutes les statistiques du secteur Culture de légumes, de melons, de racines et de tubercules
The revenue of BIOBREIZH in 2025 is 27.2 M€.
Yes, BIOBREIZH generated a net profit of 326 k€ in 2025.
The headquarters of BIOBREIZH is located in LANDIVISIAU (29400), in the department Finistere.
The tax return of BIOBREIZH is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
BIOBREIZH operates in the sector Culture de légumes, de melons, de racines et de tubercules (NAF code 01.13Z). See the 'Sector positioning' section above to compare the company with its competitors.